These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

916 related articles for article (PubMed ID: 27449597)

  • 1. Are nanotheranostics and nanodiagnostics-guided drug delivery stepping stones towards precision medicine?
    Blau R; Krivitsky A; Epshtein Y; Satchi-Fainaro R
    Drug Resist Updat; 2016 Jul; 27():39-58. PubMed ID: 27449597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted Nanotheranostics for Future Personalized Medicine: Recent Progress in Cancer Therapy.
    Jo SD; Ku SH; Won YY; Kim SH; Kwon IC
    Theranostics; 2016; 6(9):1362-77. PubMed ID: 27375785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Porphyrins and related macrocycles: Combining photosensitization with radio- or optical-imaging for next generation theranostic agents.
    Sandland J; Malatesti N; Boyle R
    Photodiagnosis Photodyn Ther; 2018 Sep; 23():281-294. PubMed ID: 30009949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oligonucleotide-based theranostic nanoparticles in cancer therapy.
    Shahbazi R; Ozpolat B; Ulubayram K
    Nanomedicine (Lond); 2016 May; 11(10):1287-308. PubMed ID: 27102380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic nanoparticles for precision oncology: theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapy.
    Zhu L; Zhou Z; Mao H; Yang L
    Nanomedicine (Lond); 2017 Jan; 12(1):73-87. PubMed ID: 27876448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fe
    Li Y; Zhang H
    Nanomedicine (Lond); 2019 Jun; 14(11):1493-1512. PubMed ID: 31215317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coating microbubbles with nanoparticles for medical imaging and drug delivery.
    Tay LM; Xu C
    Nanomedicine (Lond); 2017 Jan; 12(2):91-94. PubMed ID: 27876447
    [No Abstract]   [Full Text] [Related]  

  • 8. Towards tailored management of malignant brain tumors with nanotheranostics.
    Aparicio-Blanco J; Torres-Suárez AI
    Acta Biomater; 2018 Jun; 73():52-63. PubMed ID: 29678675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-cancer precision theranostics: a focus on multifunctional gold nanoparticles.
    Cabral RM; Baptista PV
    Expert Rev Mol Diagn; 2014 Nov; 14(8):1041-52. PubMed ID: 25314939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Versatile Nanosystem-Based Cancer Theranostics: Design Inspiration and Predetermined Routing.
    Opoku-Damoah Y; Wang R; Zhou J; Ding Y
    Theranostics; 2016; 6(7):986-1003. PubMed ID: 27217832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A PEGylation-Free Biomimetic Porphyrin Nanoplatform for Personalized Cancer Theranostics.
    Cui L; Lin Q; Jin CS; Jiang W; Huang H; Ding L; Muhanna N; Irish JC; Wang F; Chen J; Zheng G
    ACS Nano; 2015; 9(4):4484-95. PubMed ID: 25830219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gadolinium-based nanoparticles for theranostic MRI-radiosensitization.
    Lux F; Sancey L; Bianchi A; Crémillieux Y; Roux S; Tillement O
    Nanomedicine (Lond); 2015; 10(11):1801-15. PubMed ID: 25715316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic nanocarriers: Evolution of spinel ferrites for medical applications.
    Amiri M; Salavati-Niasari M; Akbari A
    Adv Colloid Interface Sci; 2019 Mar; 265():29-44. PubMed ID: 30711796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoparticle Diagnostics and Theranostics in the Clinic.
    Pallares RM; Mottaghy FM; Schulz V; Kiessling F; Lammers T
    J Nucl Med; 2022 Dec; 63(12):1802-1808. PubMed ID: 36302654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer-Targeted Nanotheranostics: Recent Advances and Perspectives.
    Ma Y; Huang J; Song S; Chen H; Zhang Z
    Small; 2016 Sep; 12(36):4936-4954. PubMed ID: 27150247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational Design of Biomolecular Templates for Synthesizing Multifunctional Noble Metal Nanoclusters toward Personalized Theranostic Applications.
    Yu Y; Mok BY; Loh XJ; Tan YN
    Adv Healthc Mater; 2016 Aug; 5(15):1844-59. PubMed ID: 27377035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanotheranostics, a future remedy of neurological disorders.
    Sharma M; Dube T; Chibh S; Kour A; Mishra J; Panda JJ
    Expert Opin Drug Deliv; 2019 Feb; 16(2):113-128. PubMed ID: 30572726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hybrid protein-inorganic nanoparticles: From tumor-targeted drug delivery to cancer imaging.
    Elzoghby AO; Hemasa AL; Freag MS
    J Control Release; 2016 Dec; 243():303-322. PubMed ID: 27794493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Voyage of theranostic liposomes for imaging and therapy.
    Sachin M; Sachin D; Dinesh S
    J Cosmet Laser Ther; 2017 Aug; 19(4):245-249. PubMed ID: 28135901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineered Hybrid Nanoparticles for On-Demand Diagnostics and Therapeutics.
    Nguyen KT; Zhao Y
    Acc Chem Res; 2015 Dec; 48(12):3016-25. PubMed ID: 26605438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.